Compare CNSP & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNSP | RVSN |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.9M |
| IPO Year | 2019 | 2018 |
| Metric | CNSP | RVSN |
|---|---|---|
| Price | $5.25 | $3.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.6K | ★ 17.0K |
| Earning Date | 11-16-2026 | 08-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $169.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $0.17 |
| 52 Week High | $10.59 | $9.39 |
| Indicator | CNSP | RVSN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 34.68 |
| Support Level | N/A | $3.26 |
| Resistance Level | N/A | $5.19 |
| Average True Range (ATR) | 0.00 | 0.28 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 18.92 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.